| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2007 | Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia | Ya M.B.; Chen J.-Y.; WEI-SHIUNG YANG ; Chi Y.-C.; Liou Y.-J.; Lin C.-C.; Wang Y.-C.; Lin C.-Y.; Su T.-P.; Chou P. | Journal of Clinical Psychiatry | 50 | 48 | |
| 2009 | Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: A cohort study | Bai Y.M.; Chen T.T.; WEI-SHIUNG YANG ; Chi Y.-C.; Lin C.-C.; Liou Y.-J.; Wang Y.-C.; Su T.-P.; Chou P.; Chen J.-Y. | Schizophrenia Research | 67 | 59 | |
| 2012 | Genome-wide association study of treatment refractory schizophrenia in han Chinese | Liou Y.-J.; Wang H.-H.; Lee M.-T.M.; Wang S.-C.; Chiang H.-L.; Chen C.-C.; Lin C.-H.; Chung M.-S.; Kuo C.-C.; Liao D.-L.; Wu C.-K.; CHIH-MIN LIU ; Liu Y.-L.; Hwu H.-G.; Lai I.-C.; Tsai S.-J.; Chen C.-H.; Liu H.-F.; Chou Y.-C.; Chen C.-H.; Chen Y.-T.; Hong C.-J.; Wu J.-Y. | PLoS ONE | 51 | 45 | |
| 2009 | Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics | Lin C.-C.; Bai Y.-M.; Wang Y.-C.; Chen T.-T.; Lai I.-C.; Chen J.-Y.; Chen S.-Y.; SUSAN SHUR-FEN GAU ; Liou Y.-J. | Journal of Clinical Psychopharmacology | 20 | 17 | |
| 2016 | Risk for developing dementia among patients with posttraumatic stress disorder: A nationwide longitudinal study | TSUNG-YANG WANG ; Wei H.-T.; Liou Y.-J.; Su T.-P.; Bai Y.-M.; Tsai S.-J.; Yang A.C.; Chen T.-J.; Tsai C.-F.; Chen M.-H. | Journal of Affective Disorders | 30 | 28 |
